Motive Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$318K Buy
2,473
+240
+11% +$28.1K 0.13% 71
2026
Q1
$269K Buy
2,233
+29
+1% +$3.35K 0.13% 73
2025
Q4
$232K Buy
+2,204
New +$207K 0.1% 82
2025
Q2
Sell
-2,578
Closed -$231K 88
2025
Q1
$231K Sell
2,578
-486
-16% -$45.4K 0.12% 61
2024
Q4
$305K Buy
3,064
+194
+7% +$20K 0.16% 58
2024
Q3
$355K Hold
2,870
0.21% 47
2024
Q2
$355K Buy
2,870
+16
+0.6% +$2.06K 0.21% 47
2024
Q1
$377K Buy
+2,854
New +$352K 0.23% 46
2023
Q4
Sell
-2,486
Closed -$256K 48
2023
Q3
$256K Sell
2,486
-220
-8% -$23.7K 0.28% 41
2023
Q2
$312K Buy
2,706
+85
+3% +$9.65K 0.32% 40
2023
Q1
$279K Sell
2,621
-239
-8% -$25.8K 0.3% 41
2022
Q4
$317K Buy
2,860
+380
+15% +$38.8K 0.24% 45
2022
Q3
$214K Buy
+2,480
New +$221K 0.17% 57

Other funds holding MRK

Motive Wealth Advisors's MRK Position: Q2 2026 in Review

Motive Wealth Advisors increased its Merck (MRK) stake by 11% in Q2 2026, buying an estimated $28.1K and bringing the position to 2,473 shares worth $318K. The position accounts for 0.13% of the portfolio, ranked #71.

Motive Wealth Advisors first reported a position in MRK in Q3 2022 and has held it in 13 quarters since. The position peaked at $377K in Q1 2024. 988 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Motive Wealth Advisors held 2,473 shares of Merck worth $318K as of Q2 2026.
  • Motive Wealth Advisors bought 240 Merck shares in Q2 2026, an estimated $28.1K.
  • Merck made up 0.13% of Motive Wealth Advisors's portfolio in Q2 2026, its #71 holding.
  • Motive Wealth Advisors first reported a position in Merck in Q3 2022 and has held it in 13 quarters since.
  • Motive Wealth Advisors's Merck position peaked at $377K in Q1 2024.
  • 988 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Motive Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.